Patents Assigned to Callaghan Innovation Research Limited
  • Publication number: 20150290494
    Abstract: An arm rehabilitation system for exercising a user's arm. The system provides an arm support device moveable upon a support surface by a user's first arm. The arm support device has a main body configured to movably engage the support surface on one side and has a hand support portion on an opposing side at or toward one end of the body for supporting a user's hand of the first arm. A primary hand support formation protrudes from the hand support portion and a secondary hand support handle extends from the main body at or toward the periphery of the hand support portion. An adjustable switch support boom assembly is also mounted to the main body and has at least one operable user input component for generating an actuation signal in response to operation by the user. An onboard motion tracking system mounted to or within the main body is configured to sense motion of the main body to enable user interaction with an interactive computer system running an application program.
    Type: Application
    Filed: November 30, 2012
    Publication date: October 15, 2015
    Applicant: Callaghan Innovation Research Limited
    Inventor: Marcus King
  • Publication number: 20150210701
    Abstract: Methods of treating infections due to Helicobacter pylori (H. pylori), in particular in subjects having a peptic ulcer, are disclosed where the methods comprise administering inhibitors of H. pylori MTAN (5?-methylthioadenosine nucleosidase) to the subject.
    Type: Application
    Filed: August 7, 2013
    Publication date: July 30, 2015
    Applicants: ALBERTEINSTIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY, CALLAGHAN INNOVATION RESEARCH LIMITED
    Inventors: Vern L. Schramm, Shanzhi Wang, Antti Marko Haapalainen, Gary Brian Evans, Richard Hubert Furneaux, Keith Clinch, Peter Charles Tyler, Shivali Ashwin Gulab
  • Publication number: 20140051659
    Abstract: The invention relates generally to oligosaccharide compounds and the use of these compounds as pharmaceuticals for treating diseases or conditions in which it is desirable to inhibit ?-secretase.
    Type: Application
    Filed: March 9, 2012
    Publication date: February 20, 2014
    Applicants: The University of Liverpool, Callaghan Innovation Research Limited
    Inventors: Ralf Schwoerer, Jeremy E. Turnbull, Peter Charles Tyler, Olga Vladimirovna Zubkova